SCHEMBL8524293

SCHEMBL8524293

COc1nc2cc(Cl)c(Cl)c(N(C(N)CS(=O)(=O)c3nccn3C)S(C)(=O)=O)c2nc1OC

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8524581 0.77 MCL1 (0.34)
SCHEMBL8649192 0.75 PDCD1LG2 (0.41)
SCHEMBL7466400 0.72 HTT (0.35)
SCHEMBL7473579 0.70 GLP1R (0.35) HRH4
SCHEMBL7471934 0.69 GRIN1 (0.50) HRH4
SCHEMBL8490077 0.68 GLP1R (0.31)
SCHEMBL7470542 0.68 GRIN1 (0.39) HRH4
SCHEMBL8650855 0.66 GRIN1 (0.42) HRH4
SCHEMBL7476576 0.66 GRIN1 (0.35) HRH4
SCHEMBL8649190 0.66 GRIN1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5863917-A ANXIOLYTIC AGENT, ANTICONVULSANTS, ANALGESICS AND NEUROPROTECTIVES. PFIZER, INC. (US) 1999-01-26 US disclosed
EP-0792874-A1 Quinoxaline derivatives useful in therapy Pfizer Limited (GB) 1997-09-03 EP disclosed